Point72 Asset Management
ETNB

Point72 Asset Management’s 89bio ETNB Stock Holding History

Point72 Asset Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,274,151
Closed -$23.2M – 2418
2025
Q2 		$22.3M Buy
+2,274,151
New +$18.8M 0.04% 455
2023
Q2 		– Sell
-1,021,647
Closed -$15.6M – 2346
2023
Q1 		$15.6M Sell
1,021,647
-2,967
-0.3% -$38.7K 0.05% 425
2022
Q4 		$13M Buy
+1,024,614
New +$9.22M 0.04% 463
2020
Q4 		– Sell
-55,456
Closed -$1.42M – 969
2020
Q3 		$1.42M Buy
55,456
+33,712
+155% +$1.07M 0.01% 744
2020
Q2 		$433K Buy
+21,744
New +$528K ﹤0.01% 721

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Point72 Asset Management's ETNB Position: Q3 2025 in Review

Point72 Asset Management sold out of 89bio (ETNB) in Q3 2025, closing a stake of 2,274,151 shares — an estimated $23.2M sold.

Point72 Asset Management first reported a position in ETNB in Q2 2020 and held it in 5 quarters. The position peaked at $22.3M in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Point72 Asset Management reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Point72 Asset Management sold 2,274,151 89bio shares in Q3 2025, an estimated $23.2M.
  • Point72 Asset Management first reported a position in 89bio in Q2 2020 and held it in 5 quarters.
  • Point72 Asset Management's 89bio position peaked at $22.3M in Q2 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.